Name: UMIN ID:
Unique ID issued by UMIN | UMIN000026630 |
---|---|
Receipt number | R000030579 |
Scientific Title | Prospective Comparison of SGLT-2 inhibitor, Luseogliflozin,versus GLP-1 Receptor Agonist,Dulaglutide, on Regression of Coronary Atherosclerosis with Type 2 Diabetes Mellitus who have Undergone Percutaneous Coronary Intervention: Open-label Randomized Parallel-group Trial |
Date of disclosure of the study information | 2017/04/01 |
Last modified on | 2018/03/12 08:59:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/03/21 16:45:09 | ||
2 | Update | 2017/03/21 18:21:28 | Organization Organization Organization Category of Funding Organization Co-sponsor Co-sponsor |
|
3 | Update | 2017/10/16 21:55:41 | Recruitment status |
|
4 | Update | 2018/03/12 08:59:44 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information Email1 |